Given that GDF-15 level is increased in not only patients with vascular inflammation, coronary artery disease, and heart failure [11,12], it has been unclear if the totality of evidence in the literature concur that patients with type 2 diabetes were similarly affected. This evidence concerns the gene GDF15 and type 2 diabetes mellitus.